Pneumatic Nebulizer Market to Reach USD 1.21 Billion by 2031, Driven by COPD Prevalence and Home-Based Respiratory Care
Dublin, Aug. 17, 2026 (GLOBE NEWSWIRE) -- The "Pneumatic Nebulizer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
The global pneumatic nebulizer market is projected to increase from USD 0.85 billion in 2025 to USD 0.90 billion in 2026 before reaching USD 1.21 billion by 2031. The market is forecast to expand at a compound annual growth rate of 6.03% from 2026 to 2031, supported by the rising prevalence of chronic respiratory diseases, aging populations, reimbursement expansion, and growing adoption of home-based respiratory therapy.
The market report provides value-based forecasts across portability, technology, patient age group, application, and geography. It examines portable and tabletop pneumatic nebulizers, conventional and noise-reduced compressors, and smart or digitally integrated systems. Applications covered include chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, bronchiectasis, and pneumonia.
Key Pneumatic Nebulizer Market Trends
Increasing COPD prevalence remains a major market growth driver. Ambient particulate matter accounts for 22.2% of COPD disability-adjusted life years worldwide, according to Respiratory Research. In the United States, annual COPD hospitalization costs exceed USD 24 billion, encouraging healthcare providers to consider pneumatic nebulizers for long-term maintenance therapy and post-discharge respiratory care.
Home-based respiratory therapy is also gaining momentum. Structured hospital discharge initiatives are incorporating nebulizer use into home-care protocols to improve continuity of treatment and reduce avoidable readmissions. Medicare coverage for virtual pulmonary rehabilitation is expanding access for rural communities, while telehealth monitoring and connected nebulizer platforms enable clinicians to review adherence information and adjust therapy remotely.
Competition from mesh and ultrasonic nebulizer technologies presents a significant restraint. A 2025 pediatric asthma trial found that mesh nebulizers delivered greater improvements in forced expiratory volume in one second than compressor systems. Their quiet operation, faster treatment delivery, and ability to function in multiple orientations are strengthening adoption in premium hospital and home-care settings. Pneumatic nebulizer manufacturers are responding with lower-noise compressors, compact designs, and connected functionality.
Additional market factors assessed in the report include:
Pneumatic Nebulizer Segment Analysis
Tabletop and benchtop devices accounted for 57.65% of the pneumatic nebulizer market in 2025. Their strong compressor output, dependable power supply, and capacity to support chronic COPD treatment continue to sustain demand, particularly among older patients seeking consistent performance and straightforward operation.
Portable pneumatic nebulizers are forecast to grow at a 7.06% CAGR through 2031. Miniaturized motors, rechargeable batteries, and lightweight designs are supporting adoption among patients who require respiratory treatment while traveling or working. The expansion of home healthcare is also encouraging some households to maintain both tabletop and portable devices for different treatment settings.
Conventional compressors represented 68.72% of the market in 2025, reflecting competitive pricing and established service networks. Demand remains strong among cost-sensitive healthcare providers and payers, particularly in emerging economies. Smart-connected compressors are projected to advance at a 7.42% CAGR as reimbursement for remote monitoring expands.
Noise-reduced systems are emerging as an important transitional technology, offering quieter performance without the higher pricing associated with mesh devices. Digitally integrated compressors can provide adherence records that support medication management, remote patient monitoring, and performance-based care agreements. These platforms may also create recurring software and service revenue opportunities for pneumatic nebulizer manufacturers.
Regional Market Outlook
North America held 40.15% of the global pneumatic nebulizer market in 2025. High COPD prevalence, broad insurance coverage, established distribution networks, and Medicare billing updates support adoption across hospitals and home-care environments. Canada benefits from reimbursement programs for eligible seniors, while respiratory home-care initiatives may create additional opportunities in Mexico.
Asia-Pacific is expected to record the fastest regional growth, with a 7.55% CAGR through 2031. China leads regional volume as air pollution, smoking rates, and respiratory disease incidence increase demand. India is expanding access through public-private healthcare programs for rural clinics, while Japan's aging population supports demand for quiet, connected, and premium respiratory devices.
Europe is anticipated to maintain stable growth, supported by universal healthcare coverage and clinical guidelines for COPD and cystic fibrosis treatment. Germany benefits from its developed outpatient infrastructure, while the United Kingdom's National Health Service supports device provision through primary-care channels. South America, the Middle East, and Africa remain comparatively underpenetrated, creating long-term opportunities as distributors strengthen local logistics and healthcare access.
Complete Market Report Scope
Key Topics Covered
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Accelerating COPD Prevalence & Aging Population
4.2.2 Home-Based Respiratory Therapy Adoption Surge
4.2.3 Government Reimbursement Expansion (EU, China)
4.2.4 Technological Shift to Low-Noise Smart Compressors
4.2.5 E-Commerce Boom in Compressor Replacement Kits
4.2.6 AI-Guided Adherence Platforms Bundled with Devices
4.3 Market Restraints
4.3.1 Rapid Cannibalization by Mesh & Ultrasonic Tech
4.3.2 Infection-Control & Aerosolization Safety Concerns
4.3.3 Low Reimbursement / Affordability in LMICs
4.3.4 Global Helium & Specialty-Gas Supply Constraints
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts
5.1 By Portability (Value)
5.1.1 Portable/ Handheld
5.1.2 Benchtop/ Tabletop
5.2 By Technology (Value)
5.2.1 Conventional Compressor
5.2.2 Noise-Reduced Compressor
5.2.3 Smart/ Digital-Integrated Compressor
5.3 By Patient Age Group (Value)
5.3.1 Pediatric
5.3.2 Adult
5.3.3 Geriatric
5.4 By Application (Value)
5.4.1 COPD
5.4.2 Asthma
5.4.3 Cystic Fibrosis
5.4.4 Others (Bronchiectasis, Pneumonia)
5.5 By Geography (Value)
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 India
5.5.3.3 Japan
5.5.3.4 South Korea
5.5.3.5 Australia
5.5.3.6 Rest of Asia-Pacific
5.5.4 South America
5.5.4.1 Brazil
5.5.4.2 Argentina
5.5.4.3 Rest of South America
5.5.5 Middle East and Africa
5.5.5.1 GCC
5.5.5.2 South Africa
5.5.5.3 Rest of Middle East and Africa
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Koninklijke Philips N.V.
6.3.2 Omron Corporation
6.3.3 PARI GmbH
6.3.4 Drive DeVilbiss Healthcare
6.3.5 Medtronic plc
6.3.6 Rossmax International Ltd.
6.3.7 GE HealthCare Technologies Inc.
6.3.8 Agilent Technologies Inc.
6.3.9 Briggs Healthcare
6.3.10 GF Health Products Inc.
6.3.11 Becton, Dickinson & Company
6.3.12 Salter Labs (SunMed)
6.3.13 Vyaire Medical Inc.
6.3.14 Trudell Medical International
6.3.15 Armstrong Medical Ltd.
6.3.16 Besmed Health Business Corp.
6.3.17 Allied Healthcare Products Inc.
6.3.18 Dehaier Medical Systems
6.3.19 O2 Concepts LLC
6.3.20 Well Lead Medical
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
For more information about this report visit https://www.researchandmarkets.com/r/x0isxa
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.